| Imago Rehab, Inc. | |
|
110 Canal St, 3rd Floor, Lowell, MA 01852 | |
| (617) 671-0789 | |
| (617) 250-8243 |
| Full Name | Imago Rehab, Inc. |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Neurorehabilitation |
| Location | 110 Canal St, Lowell, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205407236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XN1300X | Occupational Therapist - Neurorehabilitation | (* (Not Available)) | Primary |
| Provider Name | Kristin N Nuckols |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1003148594 PECOS PAC ID: 8325261787 Enrollment ID: I20220331001297 |
News Archive
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
Despite having the most expensive health care system, the United States ranks last overall compared to six other industrialized countries-Australia, Canada, Germany, the Netherlands, New Zealand, and the United Kingdom-on measures of health system performance in five areas: quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives, according to a new Commonwealth Fund report.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
› Verified 7 days ago
| Provider Name | John Paul Bonadonna |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1326791724 PECOS PAC ID: 1759769490 Enrollment ID: I20220608001184 |
News Archive
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
Despite having the most expensive health care system, the United States ranks last overall compared to six other industrialized countries-Australia, Canada, Germany, the Netherlands, New Zealand, and the United Kingdom-on measures of health system performance in five areas: quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives, according to a new Commonwealth Fund report.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
› Verified 7 days ago
| Provider Name | Micaela Galley |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831836022 PECOS PAC ID: 4082093489 Enrollment ID: I20220615000608 |
News Archive
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
Despite having the most expensive health care system, the United States ranks last overall compared to six other industrialized countries-Australia, Canada, Germany, the Netherlands, New Zealand, and the United Kingdom-on measures of health system performance in five areas: quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives, according to a new Commonwealth Fund report.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Imago Rehab, Inc. 110 Canal St, 3rd Floor, Lowell, MA 01852-3345 Ph: () - | Imago Rehab, Inc. 110 Canal St, 3rd Floor, Lowell, MA 01852 Ph: (617) 671-0789 |
News Archive
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
Despite having the most expensive health care system, the United States ranks last overall compared to six other industrialized countries-Australia, Canada, Germany, the Netherlands, New Zealand, and the United Kingdom-on measures of health system performance in five areas: quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives, according to a new Commonwealth Fund report.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
› Verified 7 days ago
Kristin Nuckols, OTR/L Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 110 Canal St, 3rd Floor, Lowell, MA 01852 Phone: 617-671-0789 Fax: 617-250-8243 | |
Talia Yocheved Lusterman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1071 Varnum Ave, Lowell, MA 01854 Phone: 978-446-1862 | |
Amanda Elizabeth Alboth-weinburg, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Bldg. #2, Lowell, MA 01852 Phone: 978-453-8331 | |
Mr. Russell John Deshaies, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 841 Merrimack St, Lowell, MA 01854 Phone: 978-459-0546 | |
Miss Alexandra Plazas, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Lowell, MA 01852 Phone: 978-453-8331 | |
Mrs. Danielle Leigh Ferrucci, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 30 Princeton Blvd, Lowell, MA 01851 Phone: 210-260-2067 | |
Marnie Peters, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 841 Merrimack St, Lowell, MA 01854 Phone: 978-459-0547 |